RxDoctor Payments Data

Aron Gornowicz, DO

Family Medicine · Adrian, MINPI 1265720262

Payments from drug & device makers

$2,097in general payments, 2019–2025

Across 120 payments — averaging $17.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$278
  • AbbVie$272
  • Novo Nordisk$243
  • Pfizer$223
  • Lilly USA, LLC$199
  • Biohaven Pharmaceuticals, Inc.$183
  • plus $699 from 15 others

What the payments were for

  • Food & beverage$2,097100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,097 in reported general payments places this provider in the 80th percentile of 3,945 family medicine providers in Michigan.

See all family medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$20,240
Medicare patients
51
Services billed
761

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Breo ElliptaFluticasone/Vilanterol13$4,998
Atorvastatin Calcium50$1,083
Albuterol Sulfate HfaAlbuterol Sulfate14$671
Celecoxib31$569
Ezetimibe22$449
Omeprazole28$366
Losartan Potassium18$323
Lisinopril29$322
Diclofenac Potassium14$319
Gabapentin12$297
Levothyroxine Sodium20$246
Potassium Chloride15$235
Lisinopril-HydrochlorothiazideLisinopril/Hydrochlorothiazide19$229
Metformin Hcl15$139
Carvedilol14$131

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKBreo Ellipta$116$4,99813 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,945 family medicine providers in Michigan.

Other family medicine in Adrian

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →